{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:40:49Z","timestamp":1778856049405,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["295334"],"award-info":[{"award-number":["295334"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["307232"],"award-info":[{"award-number":["307232"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jamda.2018.11.012","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T22:36:52Z","timestamp":1546987012000},"page":"751-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Piia","family":"Lavikainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjaana","family":"Koponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2018.11.012_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-180594","article-title":"Incidence and prevalence of antiepileptic medication use in community-dwelling persons with and without Alzheimer\u2019s disease","volume":"66","author":"Sarycheva","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.11.012_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2011-110200","article-title":"Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland","volume":"26","author":"Bell","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.11.012_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","article-title":"Incidence rates and treatment of neuropathic pain conditions in the general population","volume":"137","author":"Dieleman","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jamda.2018.11.012_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1592\/phco.22.5.329.33192","article-title":"Strategies for optimizing antiepileptic drug therapy in elderly people","volume":"22","author":"Lackner","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jamda.2018.11.012_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: Indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.jamda.2018.11.012_bib6","doi-asserted-by":"crossref","first-page":"e009742","DOI":"10.1161\/JAHA.118.009742","article-title":"Antiepileptic drug use and the risk of stroke among community-dwelling persons with Alzheimer\u2019s disease: A\u00a0matched cohort study","volume":"7","author":"Sarycheva","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jamda.2018.11.012_bib7","doi-asserted-by":"crossref","first-page":"372.e1","DOI":"10.1016\/j.jamda.2017.12.099","article-title":"Fall-risk-increasing drugs: A\u00a0systematic review and meta-analysis: III. Others","volume":"19","author":"Seppala","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2018.11.012_bib8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.63.10_suppl_4.S3","article-title":"Pharmacogenetics and enzyme induction\/inhibition properties of antiepileptic drugs","volume":"63","author":"Anderson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2018.11.012_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1715163517690744","article-title":"Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: A systematic review","volume":"150","author":"Maximos","year":"2017","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.jamda.2018.11.012_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2014.04.018","article-title":"Association between use of antiepileptic drugs and fracture risk: A systematic review and meta-analysis","volume":"64","author":"Shen","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jamda.2018.11.012_bib11","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.eplepsyres.2005.07.017","article-title":"Pharmacological and clinical aspects of antiepileptic drug use in the elderly","volume":"68","author":"Perucca","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jamda.2018.11.012_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2146\/ajhp080267","article-title":"Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007","volume":"66","author":"Vassilev","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jamda.2018.11.012_bib13","doi-asserted-by":"crossref","first-page":"41035","DOI":"10.1038\/srep41035","article-title":"Potentially high-risk medication categories and unplanned hospitalizations: A case-time-control study","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jamda.2018.11.012_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1528-1157.2002.043s2037.x","article-title":"Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs","volume":"43","author":"Spina","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.jamda.2018.11.012_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.amjopharm.2011.09.002","article-title":"Valproic acid-induced parkinsonism in the elderly: A comprehensive review of the literature","volume":"9","author":"Mahmoud","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2018.11.012_bib16","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.yebeh.2003.11.008","article-title":"Cognitive side effects of antiepileptic drugs","volume":"5","author":"Ortinski","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jamda.2018.11.012_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1528-1167.2010.02966.x","article-title":"The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"Zaccara","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jamda.2018.11.012_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/17425255.2012.645535","article-title":"Choice of antiepileptic drugs for the elderly: Possible drug interactions and adverse effects","volume":"8","author":"Jankovic","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jamda.2018.11.012_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1176\/appi.ps.201300093","article-title":"Risk of hospitalization and use of first- versus second-generation antipsychotics among nursing home residents","volume":"65","author":"Aparasu","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jamda.2018.11.012_bib20","doi-asserted-by":"crossref","first-page":"e012100","DOI":"10.1136\/bmjopen-2016-012100","article-title":"Cohort profile: The Finnish Medication and Alzheimer's disease (MEDALZ) study","volume":"6","author":"Tolppanen","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2018.11.012_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription medication purchases to medication use periods\u2014A second generation method (PRE2DUP)","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jamda.2018.11.012_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/CLEP.S116160","article-title":"Agreement between PRE2DUP register data modeling method and comprehensive medication use interview among older persons","volume":"8","author":"Taipale","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jamda.2018.11.012_bib25","doi-asserted-by":"crossref","first-page":"e0184070","DOI":"10.1371\/journal.pone.0184070","article-title":"Medication exposure in register-based research\u2014An expert-opinion based evaluation of methods","volume":"12","author":"Tanskanen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2018.11.012_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1751-9004.2007.00054.x","article-title":"An introduction to latent class growth analysis and growth mixture modeling","volume":"2","author":"Jung","year":"2008","journal-title":"Soc Personal Psychol Compass"},{"key":"10.1016\/j.jamda.2018.11.012_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modelling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.jamda.2018.11.012_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10182-011-0171-4","article-title":"Growth mixture models in longitudinal research","volume":"95","author":"Reinecke","year":"2011","journal-title":"Adv Stat Anal"},{"key":"10.1016\/j.jamda.2018.11.012_bib29","series-title":"Mplus User\u2019s Guide","author":"Muth\u00e9n","year":"1998"},{"key":"10.1016\/j.jamda.2018.11.012_bib30","doi-asserted-by":"crossref","first-page":"e008365","DOI":"10.1136\/bmjopen-2015-008365","article-title":"Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: A population-based cohort study","volume":"5","author":"Renoux","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2018.11.012_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neucli.2015.12.007","article-title":"Dysphagia in Alzheimer's disease","volume":"46","author":"Se\u00e7il","year":"2016","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.jamda.2018.11.012_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/pmj.78.924.621","article-title":"Bronchiolitis obliterans and organising pneumonia caused by carbamazepine and mimicking community acquired pneumonia","volume":"78","author":"Banka","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jamda.2018.11.012_bib33","series-title":"Working group set up by the Finnish Medical Society Duodecim, the Finnish Society of Anaesthesiologists and the Finnish Association for General Practice","article-title":"Current Care Guideline (in Finnish)","year":"2015"},{"key":"10.1016\/j.jamda.2018.11.012_bib34","series-title":"Working group appointed by the Finnish Medical Society Duodecim, Societas Gerontologica Fennica, Finnish Geriatricians, the Finnish Neurological Society, Finnish Psychogeriatric Association and the Finnish Association for General Practice","article-title":"Current Care Guideline (in Finnish)","year":"2017"},{"key":"10.1016\/j.jamda.2018.11.012_bib35","first-page":"5","article-title":"American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition","volume":"164","author":"Rabins","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2018.11.012_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish hospital discharge register: A systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861018306443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861018306443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:19:03Z","timestamp":1761506343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861018306443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1525861018306443"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2018.11.012","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}